The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus

Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inf lammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion of the bDMARDs market in Korea, reports of serious adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Eun-Jung, Kim, Hyungjin, Jung, Seung Min, Sung, Yoon-Kyoung, Baek, Han Joo, Lee, Jisoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960050/
https://www.ncbi.nlm.nih.gov/pubmed/31935319
http://dx.doi.org/10.3904/kjim.2019.411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960050/
https://www.ncbi.nlm.nih.gov/pubmed/31935319
http://dx.doi.org/10.3904/kjim.2019.411

Ejemplares similares